Gehrman, Jacob http://orcid.org/0000-0001-7385-8436
Angenete, Eva
Björholt, Ingela
Lesén, Eva
Haglind, Eva
Funding for this research was provided by:
Cancerfonden (2016/362)
Västra Götalandsregionen (4307771)
Anna-Lisa and Bror Björnssons Foundation
Article History
Received: 25 March 2019
Accepted: 9 October 2019
First Online: 17 October 2019
Compliance with ethical standards
:
: Eva Angenete reports grant from Sahlgrenska University Hospital, ALF Agreement concerning research and education of doctors (ALFGBG-716581). Ingela Björholt and Eva Lesén reports remuneration for work paid to employer (PharmaLex Sweden AB) from University of Gothenburg, during the conduct of the study. Eva Haglind reports Grants from Swedish Cancer Society (2016-362), grants from ALF-Gbg (4307771) during the conduct of the study. Jacob Gehrman have no conflicts of interest or financial ties to disclose.